1,900 Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Purchased by SeaCrest Wealth Management LLC
SeaCrest Wealth Management LLC bought a new stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,900 shares of the biopharmaceutical company’s stock, valued at approximately $251,000. A number of other institutional investors and […]
